Packaging Operations Technical Subcommittee
|
|
- Letitia West
- 5 years ago
- Views:
Transcription
1
2 and Sterile About the Presenter John Derek Thompson Lead Sterile Engineer, DePuy Synthes Certified Professional with the IOPP Member of the Medical Device Technical Committee Chairman of the Member of the Institute of Environmental Sciences and Technology
3 and Sterile Introduction Medical Device Manufacturing is a heavily regulated industry. Important is the awareness of the regulations and standards that speak to compliance in facilities and environmental control. Combination medical devices add an additional consideration where pharmaceutical regulations also apply. Seeing your controlled environment facilities as an integral part of your Sterile process helps to assure the success of your process development project and ongoing compliance.
4 and Sterile Standards and Regulations at a Glance ISO Hygiene has become increasingly important in many areas of modern society. In such areas, hygiene or biocontamination control methods are, or will be, used to create safe and stable products. International trade in hygiene-sensitive products has greatly increased. At the same time, the use of antimicrobial agents has been reduced or forbidden, creating a need for increased biocontamination control. many factors besides cleanliness must be considered in the design, specification, operation and control of cleanrooms and associated controlled environments.
5 and Sterile Standards and Regulations at a Glance CFR 21; Subchapter H; Part 820; Subpart G - Buildings shall be of suitable design and contain sufficient space to perform necessary operations, prevent mix-ups and assure orderly handling. ISO (Part 2) The sterile barrier system shall be assembled under appropriate environmental conditions to minimize the risk posed by contaminants to the medical device. ISO If work environment conditions can have an adverse effect on product quality, the organization shall establish documented requirements for the work environment conditions and documented procedures or work instructions to monitor and control these work environment conditions.
6 and Sterile Standards and Regulations at a Glance CFR 21; Chapter I; Subchapter C; Part 211 Any building or buildings used in the manufacture, processing, packing, or holding of a drug product shall be of suitable size, construction and location to facilitate cleaning, maintenance, and proper operations. GUI-0001; C Premises layout is designed to avoid mix-ups and generally optimize the flow of personnel and materials.
7 and Sterile Process Layout and Controlled Environment Design Key Points to Consider: How much space is needed for the process? Design the environment around the process and not the other way around. Lean tools can optimize process flows and minimize waste of space. Space design should account for strategic capacity growth. Remember to consider airflow requirements, critical points of product exposure and potentials for turbulence.
8 and Sterile Risk Management in Controlled Environment Design Guidance/requirements examples ISO (Part 2) The sterile barrier system shall be assembled under appropriate environmental conditions to minimize the risk posed by contaminants to the medical device. Potential failure modes and action levels having the greatest impact on the process should be identified and addressed (failure mode and effects analysis, cause and effect analysis).
9 and Sterile Risk Management in Controlled Environment Design Guidance/requirements examples (continued) EudraLex - Volume 4 (Chapter 3) [Premises] Their layout and design must aim to minimise the risk of errors and permit effective cleaning and maintenance in order to avoid cross-contamination, build up of dust or dirt and, in general, any adverse effect on the quality of products. Both the European Commission GMP and Health Canada speak to the environment that, when considered together with measures to protect the manufacturing processes, presents minimal risk of causing contamination of materials or products.
10 and Sterile Risk Management in Controlled Environment Design A risk based approach should be taken in the design of the controlled environment. Risk analysis should be a collaborative effort acquiring input from Subject Matter Expert groups including (but not limited to) Product Development, Engineering, Sterility Assurance, Manufacturing and Facilities. Risk analysis serves to determine where process controls are required in order to mitigate risk. For medical device, non-conformances are classified based on patient risk. The controlled environment design and function should serve to mitigate the risks associated with the potential for product contamination.
11 and Sterile Facilities Capability Assessment Key Questions to Answer: What utilities are needed to support the room and operate the equipment within it? Controlled environment support equipment requirements must match facility support capabilities unless facility additions or modifications are possible. Are there special environmental support requirements? Depending on the product requirements and the lead-in process, environmental requirements can be from unclassified controlled areas to much more controlled (even aseptic) levels. Will an existing space be converted or is new construction required?
12 and Sterile User Requirements Specification (Primarily based on guidance from ISO ) Must be developed and agreed upon. Well developed URS serves as the controlled environment project plan. Should be developed with the relative Subject Matter Expert groups including (but not limited to) Product Development, Engineering, Sterility Assurance, Manufacturing and Facilities. Defines the requirements of the product, process and controlled environment. Sets the scope of the controlled environment project and serves as reference guide for design review.
13 and Sterile User Requirements Specification (Primarily based on guidance from ISO ) Defines the purpose of the room. Identifies the segregation control concept to be employed for the controlled environment and clean zones within it. Defines key regulatory elements the design must conform to such as building, environmental and safety, and good manufacturing practice guidelines. Includes (at a minimum): If new or revision/upgrade Intended use
14 and Sterile User Requirements Specification (Primarily based on guidance from ISO ) Includes (at a minimum): Process description and flow Equipment list with equipment description, intended process use, utility requirements, heat generation, etc... Construction type Clean zone description, number of zones and ISO class requirements per zone Air Change Rate Air Handling Unit specification
15 and Sterile User Requirements Specification (Primarily based on guidance from ISO ) Includes (at a minimum): Filter specification (% efficiency rating and sizes) Parametric requirements of the segregation concept chosen Environmental monitoring requirements and planned methods Materials of construction The completed project plan shall be reviewed and agreed upon.
16 and Sterile Key Terms (Per ISO ) Occupancy States As-Built - Condition where the installation is complete with all services connected and functioning but with no production equipment, materials, or personnel present. At-Rest - Condition where the installation is complete with equipment installed and operating in a manner agreed upon by the customer and supplier, but with no personnel present. Operational - Condition where the installation is functioning in the specified manner, with the specified number of personnel present and working in the manner agreed upon.
17 and Sterile Commissioning Per ISO : Planned and documented series of inspections, adjustments and tests carried out systematically to set the installation into correct technical operation as specified. Carried out in the As-Built state. Assures installation is ready for qualification. No, not that one Testing required depends on the intended use of the room, ISO classification and design layout.
18 and Sterile Certification Certify [Merriam-Webster] To say officially that something or someone has met certain standards or requirements. In cleanrooms, certification is documenting that the room and/or clean zone meets the acceptance criteria that demonstrates meeting a given ISO classification. This also includes (as applicable): airflow, filter, temperature, humidity, lighting, noise and segregation concept related testing.
19 and Sterile Validation CFR 21; Subchapter H; Part 820; Subpart G Where the results of a process cannot be fully verified by subsequent inspection and test, the process shall be validated with a high degree of assurance and approved according to established procedures. The validation activities and results, including the date and signature of the individual(s) approving the validation and where appropriate the major equipment validated, shall be documented.
20 and Sterile Validation For cleanrooms validations, we consider the total aspect of intended performance under specified conditions, not just the particle counts that serve to meet a given ISO classification. Ensures the controlled environment is designed per specifications, is functioning as intended, and can consistently meet the intended use of the area. Validation testing is performed in each of the occupancy states to demonstrate proper function and ability to maintain the environment under that given condition.
21 and Sterile Considerations in Standard Operating Procedures Procedures that govern operation of and within the controlled environment must be established. Procedures cover: Maintenance and cleaning Personnel gowning, conduct and hygiene Environmental monitoring requirements Non-conformance handling and remediation (including disaster recovery)
22 and Sterile Considerations in Standard Operating Procedures Procedures cover: Record requirements to document compliance to procedures, regulations and standards (includes requirements for record retention). Change Control. Requirements for training and certification.
23 and Sterile Considerations in Personnel ISO The organization shall establish documented requirements for health, cleanliness and clothing of personnel if contact between such personnel and the product or work environment could adversely affect the quality of the product. The organization shall ensure that all personnel who are required to work temporarily under special environmental conditions within the work environment are appropriately trained or supervised by a trained person.
24 and Sterile Considerations in Personnel ISO Personnel shall be instructed in hygiene-related issues that will prepare them for properly working in the cleanroom environment. A policy concerning jewelry, cosmetics and similar materials that can cause contamination problems shall be determined. Cleanroom personnel shall be trained to conduct themselves in a manner that minimizes generation of contamination which can be transferred or deposited on or into the product.
25 and Sterile Ongoing Maintenance CFR 21; Subchapter H; Part 820; Subpart G - Each manufacturer shall establish and maintain schedules for the adjustment, cleaning, and other maintenance of equipment to ensure that manufacturing specifications are met. Maintenance activities, including the date and individual(s) performing the maintenance activities, shall be documented.
26 and Sterile Ongoing Maintenance Maintenance activities must be designed to limit or prevent negative impact to environmental control. This not only includes maintenance on the room itself, but on the process equipment within it and the support utilities as well. Downtime expectations (where applicable) should be established and planned for as well as standard restoration activities such as cleaning and testing following completion of scheduled maintenance. Maintenance and repairs must be well documented and consider where re-validation may be required following certain repairs.
27 and Sterile Ongoing Monitoring ISO Continued compliance with air cleanliness (ISO class) requirements specified for the installation is verified by performing specified tests and by documenting the results. Monitoring data is used as an indication of installation status and may determine the frequency with which tests are carried out. ISO The user of a cleanroom or controlled environment shall set microbiological alert and action levels. These levels shall be appropriate to the field of application, to the classification of the risk zones and to what is achievable using current technology. ISO Detection and monitoring of biocontamination in risk zones shall be carried out by sampling and enumerating viable units with appropriate methods in accordance with a sampling plan.
28 and Sterile Ongoing Monitoring (Primarily based on guidance from ISO ) Good monitoring program Is not just based on measuring non-viable particles to meet ISO Must be established, implemented, trained to, and maintained. Is an integral part of the quality system. Is based on an appropriate risk assessment. Has established alert and action limits and established corrective actions. Has established documentation and document retention requirements. Has limits set based on sampling at a given occupancy state.
29 and Sterile Ongoing Monitoring (Primarily based on guidance from ISO ) Good monitoring program Is conducted using a sampling device appropriate for the sample to be collected and the area being monitored. Has established frequency and sampling location requirements. Has procedure for storing, transporting and processing of samples and evaluations of results. Includes trending to identify patterns in results. Must not itself present a contamination risk by its execution.
30 and Sterile Audit Preparation Some thoughts from the codes: ISO 11607, Part 2 - Periodic revalidation or reviews should be considered since multiple minor changes could cumulatively affect the validation status of the process. CFR 21; Subchapter H; Part 820; Subpart G Each manufacturer shall establish procedures for quality audits and conduct such audits to assure that the quality system is in compliance with the established quality system requirements and to determine the effectiveness of the quality system.
31 and Sterile Audit Preparation Know the relative regulations and standards and have a system for notification of updates. Conduct frequent self audits. Consider a DMAIC approach continuously improve, optimize and re-stabilize the controlled environment design and operations. Know the relative regulations and standards and have a system for notification of updates. (Yes I wrote it twice).
32 and Sterile Final Thoughts ISO Many factors besides airborne particulate cleanliness should be considered in the design, specification, operation and control of cleanrooms and other controlled environments. In some circumstances, relevant regulatory agencies may impose supplementary policies or restrictions. In such situations, appropriate adaptations of the standard testing procedures may be required.
33 and Sterile Conclusion In the Sterile Pack of medical devices, combination medical devices and pharmaceuticals, the sterile pack controlled environment, design, people and operations are integral parts of the packaging process control. Considering them as such better assures the success of your sterile packaging process development project and ongoing compliance.
34 and Sterile Questions?
35 Learn more about membership and support of the Task Group of the Medical Device Technical Committee at the Institute of Professionals webpage at or contact John Derek Thompson at
Packaging Operations Technical Subcommittee
Documentation About the Presenter John Derek Thompson Lead Sterile Engineer, DePuy Synthes Certified Professional with the IOPP Member of the Medical Device Technical Committee Chairman of the Member of
More informationISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods
INTERNATIONAL STANDARD ISO 14698-1 First edition 2003-09-01 Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods Salles propres et environnements
More informationSupplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4.
Supplementary Training Modules on Good Manufacturing Practice Validation WHO Technical Report Series, No. 937, 2006. Annex 4. Validation Slide 1 of 48 August 2006 Validation! Part 1. General overview on
More informationHVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction
HVAC and Risk Management RACI Meeting 7 th December 2011 Dr Stephen Firmer Asia Pacific Consultants Pty Ltd Agenda Context Project Management Design Construction Qualification Routine Control /Potential
More informationBaxa Corporation. Technical Paper. Environmental Controls for Sterile Compounding
Baxa Corporation Environmental Controls for Sterile Compounding Technical Paper A guidance document on developing sterile preparation areas to meet the USP requirements for low and medium risk compounded
More informationCorrespondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements
Correspondence Between and 21 CFR Part 820 QMS Requirements 10411 Corporate Drive, Suite 102, Pleasant Prairie, WI 53158 262.842.1250 262.842.1240 info@rcainc.com rcainc.com 2 4 Quality Management System
More informationISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Part 4: Design, construction and start-up
INTERNATIONAL STANDARD ISO 14644-4 First edition 2001-04-01 Cleanrooms and associated controlled environments Part 4: Design, construction and start-up Salles propres et environnements maîtrisés apparentés
More informationQuality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702
Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 11 Status : APPROVED Effective: 09/07/2017 Page 2 of 32 Quality Manual Table of Contents
More informationGENERIC QUALITY ASSURANCE REQUIREMENTS FOR: BUILT TO PRINT ITEMS, ITEMS TO STANDARD AND OFF THE SHELF ITEMS
GENERIC QUALITY ASSURANCE REQUIREMENTS FOR: BUILT TO PRINT ITEMS, ITEMS TO STANDARD AND OFF THE SHELF ITEMS APPLICABLE FOR: AIRBUS DEFENCE AND SPACE - SPACE BUSINESS UNIT ORBITAL ISSUE: 02c RELEASE DATE:
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness
INTERNATIONAL STANDARD ISO 14644-1 First edition 1999-05-01 Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness Salles propres et environnements maîtrisés apparentés
More informationFDA s Guidance for Industry
Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance
More informationPERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM
Page 1 of 24 PERFORMANCE QUALIFICATION PROTOCOL FOR HVAC SYSTEM Signing of this Performance Qualification Protocol indicates agreement with the Validation Master Plan approach of the equipment. Further
More informationPharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD
Pharmaceutical Compounding Sterile and Nonsterile Preparations Jeanne Sun, PharmD Agenda Legal Framework Overview Pharmaceutical Compounding Nonsterile Preparations Pharmaceutical Compounding
More informationWebinar. The New EU-GMP Annex 1 draft Dupont. GOP-Innovations your Partner for Practical Training and e-learning. 8 June 2018
Webinar The New EU-GMP Annex 1 draft Dupont 8 June 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, consultant, trainer, coach 10 years
More informationEU and FDA GMP Regulations: Overview and Comparison
THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational
More informationCorrespondence between ICMED criteria and ISO 13485: 2012
Annexure A (Informative) Correspondence between ICMED 13485 criteria and ISO 13485: 2012 Green Font is additional ICMED 13485 criteria requirement. Additional ICMED 13485 criteria Requirements are also
More informationc) Have personnel been appointed to supervise the production operations across all shifts in order to ensure the product quality?
Factory s Quality Assurance Ability 1 Responsibilities and Resources 1.1 Responsibilities a) Have the responsibilities and interrelation of various personnel involved in quality activities been defined?
More informationRecent USP Updates May, 2013
Recent USP Updates May, 2013 Don Singer GSK Bioburden Control of Non-sterile Drug Substances and Products The chapter emphasizes control as a risk mitigation strategy The chapter recommends a risk-based
More informationVALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY
VALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY Oren Levin, Diane Gordon VisionCare Ophthalmic Technologies, POB 3879, Petah Tikva 49130,
More informationOverview and Introduction Annex 1 Revision
Overview and Introduction Annex 1 Revision Paul Moody, Inspector Pharmig Current Hot Topics in Pharmaceutical Microbiology, Dublin May 30 th, 2018 Scope History Process of Revision Rationale for Revision
More informationCompounding Aseptic Isolators (CAI) James T Wagner
Compounding Aseptic Isolators (CAI) James T Wagner jimwagner@cenvironment.com Disclaimer "Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity
More informationAAMI Quality Systems White Paper
AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017, Updated February 2018 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward,
More informationISO 13485:2016 The Final Countdown
ISO 13485:2016 The Final Countdown 03 April 2018 Robert G. Ruff Executive Director, Medical Device Certification and Training 1 This document is intended to facilitate an oral briefing. It is not intended
More informationContamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC
Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC Contamination risk levels differ in aseptic, and non-sterile and terminally sterilized
More informationTrotz sorgfältiger inhaltlicher Prüfung übernehmen wir keine Haftung für die Richtigkeit und Aktualität für Unterlagen von Dritten.
Trotz sorgfältiger inhaltlicher Prüfung übernehmen wir keine Haftung für die Richtigkeit und Aktualität für Unterlagen von Dritten. IFS HPC Issue 2 Joachim Mehnert Technical Director DQS CFS GmbH 23. February
More informationNQA-1 Graded Approach, 55-Gallon Drum Summary
1, Organization 2, Quality Assurance program 3, Design 4, Procurement Document 5, Instructions, procedures, and Drawings 100 Basic 200 Structure and Responsibility 201 General 202 Delegation of Work 300
More informationQuality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines
Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:
More informationASSESSMENT, CLEANING & RESTORATION OF HVAC SYSTEMS (ACR-2002)
ASSESSMENT, CLEANING & RESTORATION OF HVAC SYSTEMS (ACR-2002) C Cochrane * and T Yacobellis National Air Duct Cleaners Association ACR 2002 Committee, Washington, DC, USA ABSTRACT In the fall of 2001 NADCA
More informationQUALITY MANUAL QM0492 ISO SUPPLEMENT III
QUALITY MANUAL QM0492 ISO 13485 SUPPLEMENT III REV. ORIG Foreword This document defines the quality management system requirements to be applied when processing product for clients within the medical sector
More informationChanges in the EXCiPACT 2017 Edition Requirements from the 2012 Edition
Changes in the EXCiPACT 2017 Edition Requirements from the 2012 Edition Blue text indicates changes to both GMP and GDP requirements Orange text indicates specific changes to the GDP requirements Items
More informationMedical QMS Quality Manual
SECTION 1: SIGNATURE PAGE Medical QMS Quality Manual APPROVALS: (Approvals are electronically recorded in the eqms.) CEO/President California Division: Bruce Cleckley President Washington Division: Brad
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 14644-2 First edition 2000-09-15 Cleanrooms and associated controlled environments Part 2: Specifications for testing and monitoring to prove continued compliance with ISO 14644-1
More informationSFHPHARM18 - SQA Unit Code FA2L 04 Prepare aseptic products
Overview This standard covers the preparation of aseptic products including preparing the environment and self. It covers aseptic preparation for both dispensing and manufacturing. Your practice will be
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationMDSAP Purchasing Process
MDSAP Purchasing Process The Medical Device Single Audit Program, MDSAP, evaluates companies on their compliance to requirements based on ISO 13485:2016 and national regulations. An MDSAP audit looks at
More informationChecklist for the assessment based on the standards
ISO & MDD & Checklist for the assessment based on the standards ISO :2016 ISO :2016 associate with EC Directive 93/42 EEC Where applicable EC Directive 93/42/EEC Annex II/V/VI Company: Audit date Auditor:
More informationTHE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry.
THE GMP HANDBOOK g o o d m a n u fac t u r i n g p r ac t i c e quality systems for the pharmaceutical industry Ke y2 C om pl ia nc e AB by Anna Lundén ANNEXES Key2Compliance AB Annexes - Content Annexes
More informationSubpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.
FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis
More informationChecklist for the Auditor
Page: 1 / 17 Checklist for the Auditor Content done page Overview / Audit Elements 2-3 General Information 4-6 ACS (Audit Checklist STANDARD) P 3 7-12 Summary Corrective Actions 13-14 Possible Comments
More informationRegistered Starting Material Auditing Guide
Registered Starting Material Auditing Guide Annex 1 Aide Mémoire Company : Auditor(s) : Location, Country : Date of Audit: APIC Guide for Auditing Registered Starting Material Manufacturers Remark: Non-compliance
More informationHow to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant
How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant Randy Hutt, Ph.D. Associate Director Sterility Assurance and Microbiology Luitpold
More informationEnvironmental Monitoring of Aseptic Processing Areas - 1
Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring
More informationSFHPHARM19 - SQA Unit Code FA32 04 Prepare aseptic products and carry out in-process checking
Prepare aseptic products and carry out in-process checking Overview This standard covers the preparation of aseptic products including preparing the environment, self and in-process checking. It covers
More informationGood practices in quality control in pharmaceutical industry - Overview of regulatory guidelines
Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department
More informationWebinar Expert Module 3: GMP Inspections Dupont
Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach
More informationExcipient Certification Scheme
Excipient Certification Scheme CPhI Breakfast Briefings Feria de Madrid, 13 th October 2009 Dr Arnulf Heubner Member of the EFCG-Board and Chairman of the Pharmaceutical Business Committee (PBC) Excipient
More informationPROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT
August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline
More informationOn behalf of the PHSS Pharmaceutical and Healthcare Sciences Society (UK).
31 st March 2015 Submission of comments on ' Concept paper on the revision of annex 1 of the guidelines on good manufacturing practice manufacture of sterile medicinal products EMA/INS/GMP/735037/2014
More informationQUALITY UPDATE Q1 2018
QUALITY UPDATE Q1 2018 QUALITY LEADERSHIP Dear Valued Customer, At SCA Pharmaceuticals, Quality is the cornerstone of our business. I am pleased to provide you with our first Quality Report of 2018 which
More informationSITE MASTER FILE For MHRA
ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of
More informationGeneral European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT
General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (16) 86 R2 MANAGEMENT OF ENVIRONMENTAL CONDITIONS Full document title and reference Document type Management of Environmental
More informationEudraLex. Part I1 Chapter 6: Quality Control
EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines tofor Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Part I1 Chapter 6: Quality
More informationSTANDARDS FOR COMPOUNDING PHARMACIES
STANDARDS FOR COMPOUNDING PHARMACIES APPLICATION NOTE LC-139 (US) Introduction This publication provides excerpts from some of the many guidelines and standards that pertain to compounding pharmacies.
More informationPhEn-602 Notes # 4 J. Manfredi
PhEn-602 Notes # 4 J. Manfredi Spring 2009 1 Basic definitions Clean Room: A room in which the concentration of airborne particles is controlled and contains one or more clean zones Clean Zone: A defined
More informationGMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd
GMP Compliance George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd June 2017 Overview GMP Definition and Regulation Our Philosophy and Strategy for Compliance Project Lifecycle Deliverables Master
More informationThis compilation of the complex
Manufacturing in a Global Marketplace Reference Matrices on Regulations for Classified (Environmentally Controlled) Areas Betty Seawell, William Miele, and Jean Huxsoll The complex world of international
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex
More informationBFS IOA BFS Training 2018 Kunming Qualification and Validation of a BFS-Installation including CIP/SIP
Qualification and Validation of a BFS-Installation including CIP/SIP Presented by Christoph Bohn and Stefan Kiesel Director Rommelag Pharma Service Senior Manager Rommelag Pharma Service Coyright BFS IOA
More informationWhitepaper. High temperature HEPA filtration. Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Preview
High temperature HEPA filtration Air filtration challenges and answers for dry heat sterilization tunnels Whitepaper Preview Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Air filtration
More informationOn-Site GMP Training GMP COMPLIANCE TECHNICAL
PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program
More informationYOU RE CLOSER THAN YOU THINK
YOU RE CLOSER THAN YOU THINK ISO 13485:2016 READINESS CHECKLIST We understand that some of our customers would like to be able to check how close they are to meeting the requirements of ISO 13485:2016.
More informationDesign and Construction of Biocontainment Laboratories
Design and Construction of Biocontainment Laboratories Commissioning and Validation Benjamin MABILE Director Global Validation, GSK Biologicals GSK Biologicals Context - Vaccines Key elements of the Validation
More informationBiocontamination control in pharmaceutical production
White Paper Data Sheet Biocontamination control in pharmaceutical production and compliance to ISO 14698 with validated active microbial air samplers Tim Sandle, Ph.D., Head of Microbiology at Bio Products
More informationAnnex 4. Guidance on good manufacturing practices: inspection report. Background
Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)
More informationFacility and Operational Issues for Cord Blood Banks: FDA Draft Guidance
Facility and Operational Issues for Cord Blood Banks: FDA Draft Guidance Mary Malarkey, Director Office of Compliance and Biologics Quality ISCT 7 th Annual Somatic Cell Therapy Symposium, September 26-28,
More informationMetrology & Clean Room Technology (A complete practical course)
Metrology & Clean Room Technology (A complete practical course) In commemoration of world metrology day 2018 with the theme Constant evolution of the International System of Units, the academy of the International
More informationISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2008, Vol. 28 No. 5 This executive summary provides an overview of the second edition of the ISPE Baseline Guide:
More informationGB/T Translated English of Chinese Standard: GBT NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA
Translated English of Chinese Standard: GBT16294-2010 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 13.040.30
More informationQUALITY AGREEMENT. The following Agreement has been concluded between
QUALITY AGREEMENT The following Agreement has been concluded between LLC LABORATORIES The contract laboratory and service provider 1625 Trinity Dr., Unit 11 Mississauga, Ontario Canada L5T 1W9 Hereinafter
More informationThe ABCs and Challenges of GMP The American Experience
The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine
More informationGMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides
FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationMaster Air Parts, Inc Skyway Drive, Suite 303 Santa Maria, CA (805) Phone (805) Fax
(Please type or print) Supplier: Address: City: State: Zip: Telephone: Fax: Email: Website: Brief list of Parts, material, or services to be provided to Master Air Parts, Inc. Are you an FAA Certified
More informationSafeguarding public health. Deficiency Database Figures April June 2009
Deficiency Database Figures April June 9 Relevant Inspections Performed = Number of Critical Observations = 1 Number of Major Observations = 191 Slide Batch Release Complaint and Product Recall Sterility
More informationSupersedes Division Name Revision No. 0 Export Division Page No. 1 of 9
Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationSterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)
Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE CriticalPoint s Sterile Compounding elearning curriculum is written by industry experts and covers both Chapter and
More informationEFfCI GMP FOR COSMETIC INGREDIENTS. Revision 2017
EFfCI GMP FOR COSMETIC INGREDIENTS Including the Certification Scheme for GMP for Cosmetic Ingredients Revision 2017 Prepared by the European Federation for Cosmetic Ingredients In Collaboration with Copyright
More informationMicrobiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A
USP Antimicrobial Effectiveness Testing Microbiology Testing: Webinar Q&A 1. If a base ingredient is designed for the purpose of compounding a specific type of preparation does this forgo the necessity
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Medicinal Product quality, safety and efficacy Brussels, 16 August 2013 EudraLex The Rules Governing Medicinal
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationRevision. Quality Manual. Multilayer Prototypes. Compliant to ISO / AS9100 Rev C
1 of 29 Quality Manual Multilayer Prototypes Compliant to ISO 9001-2008 / AS9100 Rev C This Quality Manual sets forth the quality system policies and Defines compliance with the ISO 9001-2008 SAE AS 9100
More informationfor IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
More informationINSPECTOR S OBSERVATIONS AND WARNING LETTER
Microrite, Inc. San Jose, CA, USA, http://www.microrite.com AIR VELOCITY MEASUREMENTS AND CORRELATION TO SMOKE STUDIES FOR ASEPTIC OPERATIONS KEYWORDS Air Velocity, Air Flows, Smoke Study, Air Pattern
More informationProcess development and basic GMP
Process development and basic GMP Aulton Chapter 45, handouts Specification, stability, inprocess controls and validation Product development Process development Critical Product Qualities issues Critical
More informationDocumenta tion and Records
Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping
More informationMonday 8 th July Symposium 1 - Environmental Monitoring of Production Areas
Monday 8 th July 2013 Symposium 1 - Environmental Monitoring of Production Areas Dealing with Environmental Monitoring Out of Specification Results and Changes to ISO 14644 David Buckley Rev 2 1 Kaoru
More informationQM-1 QUALITY MANAGEMENT SYSTEMS MANUAL. Revision 10
QM-1 QUALITY MANAGEMENT SYSTEMS MANUAL Revision 10 Page: 1 of 54 TABLE OF CONTENTS 1. DOCUMENT REVISION HISTORY... 5 2. INTRODUCTION... 6 2.1 Purpose... 6 2.2 Scope... 7 Figure 1: Sequence and Interaction
More informationPHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 045-1 1 July 2018 GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING
More informationDeveloped and Presented by: Wisconsin Healthcare Engineering Association
Infection Control Risk Assessment (ICRA) Developed and Presented by: Wisconsin Healthcare Engineering Association What is an ICRA? An Infection Control Risk Assessment is a tool devised to protect patients
More informationImpact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut
Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813
More informationEnvironmental Monitoring of Aseptic Processing Areas - 2
Environmental Monitoring of Aseptic Processing Areas - 2 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Active Air Monitoring (Viables) Air Sieve Samplers Draw air
More informationThe procurement, qualification and calibration of lab instruments: An Overview
The procurement, qualification and calibration of lab instruments: An Overview The reliability of analytical data generated from chemical and physical analyses is critically dependent on three factors:
More informationSTAGING/STORAGE OF COMPONENTS CFR Part 50, Appendix B, Quality Assurance Criteria for Nuclear Power Plants and Fuel Reprocessing Plants
Staging/Storage of Components Page 1 of 7 1.0 Objective STAGING/STORAGE OF COMPONENTS The objective of this surveillance is to ensure that before components or consumables are used in maintenance and repair
More information10 Thorough examination and test
10 Thorough examination and test Key points Every employer s LEV system requires statutory thorough examination and testing by a competent person. The examination and testing report should have a prioritised
More informationRisk Assessment Questionnaire
Risk Assessment Questionnaire Date completed Section 1 - Supplier information Company Name: Address: Contact: Position: Telephone: Email: Emergency Out of Hours Contact Name and Number: Is this site of
More information